Gehirnveränderungen bei Schwangerschaftstoxikose

G. Wilke,E. Klees,Renate Moschel

DOI: https://doi.org/10.1007/BF00217827

Deutsche Zeitschrift für Nervenheilkunde

Abstract:

What problem does this paper attempt to address?

Potential Diaphragm Muscle Weakness-related Dyspnea Persists 2 Years after COVID-19 and Could Be Improved by Inspiratory Muscle Training: Results of an Observational and an Interventional Clinical Trial

Jens Spiesshoefer,Binaya Regmi,Mehdi Senol,Benedikt Jörn,Oscar Gorol,Mustafa Elfeturi,Stephan Walterspacher,Alberto Giannoni,Florian Kahles,Rainer Gloeckl,Michael Dreher

DOI: https://doi.org/10.1164/rccm.202309-1572OC

2024-09-01

Abstract:Rationale: Diaphragm muscle weakness might underlie persistent exertional dyspnea, despite normal lung and cardiac function in individuals who were previously hospitalized for acute coronavirus disease (COVID-19) illness. Objectives: The authors sought, first, to determine the persistence and pathophysiological nature of diaphragm muscle weakness and its association with exertional dyspnea 2 years after hospitalization for COVID-19 and, second, to investigate the impact of inspiratory muscle training (IMT) on diaphragm and inspiratory muscle weakness and exertional dyspnea in individuals with long COVID. Methods: Approximately 2 years after hospitalization for COVID-19, 30 individuals (11 women, 19 men; median age, 58 years; interquartile range [IQR] = 51-63) underwent comprehensive (invasive) respiratory muscle assessment and evaluation of dyspnea. Eighteen with persistent diaphragm muscle weakness and exertional dyspnea were randomized to 6 weeks of IMT or sham training; assessments were repeated immediately after and 6 weeks after IMT completion. The primary endpoint was change in inspiratory muscle fatiguability immediately after IMT. Measurements and Main Results: At a median of 31 months (IQR = 23-32) after hospitalization, 21 of 30 individuals reported relevant persistent exertional dyspnea. Diaphragm muscle weakness on exertion and reduced diaphragm cortical activation were potentially related to exertional dyspnea. Compared with sham control, IMT improved diaphragm and inspiratory muscle function (sniff transdiaphragmatic pressure, 83 cm H2O [IQR = 75-91] vs. 100 cm H2O [IQR = 81-113], P = 0.02), inspiratory muscle fatiguability (time to task failure, 365 s [IQR = 284-701] vs. 983 s [IQR = 551-1,494], P = 0.05), diaphragm voluntary activation index (79% [IQR = 63-92] vs. 89% [IQR = 75-94], P = 0.03), and dyspnea (Borg score, 7 [IQR = 5.5-8] vs. 6 [IQR = 4-7], P = 0.03). Improvements persisted for 6 weeks after IMT completion. Conclusions: To the best of the authors' knowledge, this study is the first to identify a potential treatment for persisting exertional dyspnea in long COVID and provide a possible pathophysiological explanation for the treatment benefit. Clinical trial registered with www.clinicaltrials.gov (NCT04854863, NCT05582642).
Continuous Femoral Nerve Blocks: Decreasing Local Anesthetic Concentration to Minimize Quadriceps Femoris Weakness

Maria Bauer,Lu Wang,Olusegun Onibonoje,C. Parrett,D. Sessler,Loran Mounir-Soliman,S. Zaky,V. Krebs,L. Buller,Michael C. Donohue,J. Stevens-Lapsley,B. Ilfeld

DOI: https://doi.org/10.1097/ALN.0b013e3182475c35

IF: 8.986

2012-03-01

Anesthesiology

Abstract:Background: Whether decreasing the local anesthetic concentration during a continuous femoral nerve block results in less quadriceps weakness remains unknown. Methods: Preoperatively, bilateral femoral perineural catheters were inserted in subjects undergoing bilateral knee arthroplasty (n = 36) at a single clinical center. Postoperatively, right-sided catheters were randomly assigned to receive perineural ropivacaine of either 0.1% (basal 12 ml/h; bolus 4 ml) or 0.4% (basal 3 ml/h; bolus 1 ml), with the left catheter receiving the alternative concentration/rate in an observer- and subject-masked fashion. The primary endpoint was the maximum voluntary isometric contraction of the quadriceps femoris muscles the morning of postoperative day 2. Equivalence of treatments would be concluded if the 95% CI for the difference fell within the interval −20%–20%. Secondary endpoints included active knee extension, passive knee flexion, tolerance to cutaneous electrical current applied over the distal quadriceps tendon, dynamic pain scores, opioid requirements, and ropivacaine consumption. Results: Quadriceps maximum voluntary isometric contraction for limbs receiving 0.1% ropivacaine was a mean (SD) of 13 (8) N · m, versus 12 (8) N · m for limbs receiving 0.4% [intrasubject difference of 3 (40) percentage points; 95% CI −10–17; P = 0.63]. Because the 95% CI fell within prespecified tolerances, we conclude that the effect of the two concentrations were equivalent. Similarly, there were no statistically significant differences in secondary endpoints. Conclusions: For continuous femoral nerve blocks, we found no evidence that local anesthetic concentration and volume influence block characteristics, suggesting that local anesthetic dose (mass) is the primary determinant of perineural infusion effects.
Options and processes for spent catalyst handling and utilization.

M. Marafi,A. Stanislaus

DOI: https://doi.org/10.1016/S0304-3894(03)00145-6

IF: 13.6

2003-07-18

Journal of Hazardous Materials

Abstract:
Persistent Fatigue, Weakness, and Aberrant Muscle Mitochondria in Survivors of Critical COVID-19

Kirby P Mayer,Ahmed Ismaeel,Anna G Kalema,Ashley A Montgomery-Yates,Melissa K Soper,Philip A Kern,Jonathan D Starck,Stacey A Slone,Peter E Morris,Esther E Dupont-Versteegden,Kate Kosmac

DOI: https://doi.org/10.1097/CCE.0000000000001164

2024-10-16

Abstract:Objectives: Persistent skeletal muscle dysfunction in survivors of critical illness due to acute respiratory failure is common, but biological data elucidating underlying mechanisms are limited. The objective of this study was to elucidate the prevalence of skeletal muscle weakness and fatigue in survivors of critical illness due to COVID-19 and determine if cellular changes associate with persistent skeletal muscle dysfunction. Design: A prospective observational study in two phases: 1) survivors of critical COVID-19 participating in physical outcome measures while attending an ICU Recovery Clinic at short-term follow-up and 2) a nested cohort of patients performed comprehensive muscle and physical function assessments with a muscle biopsy; data were compared with non-COVID controls. Setting: ICU Recovery Clinic and clinical laboratory. Patients/subjects: Survivors of critical COVID-19 and non-COVID controls. Interventions: None. Measurements and main results: One hundred twenty patients with a median of 56 years old (interquartile range [IQR], 42-65 yr old), 43% female, and 33% individuals of underrepresented race attended follow-up 44 ± 17 days after discharge. Patients had a median Acute Physiology and Chronic Health Evaluation-II score of 24.0 (IQR, 16-29) and 98 patients (82%) required mechanical ventilation with a median duration of 14 days (IQR, 9-21 d). At short-term follow-up significant physical dysfunction was observed with 93% of patients reporting generalized fatigue and performing mean 218 ± 151 meters on 6-minute walk test (45% ± 30% of predicted). Eleven patients from this group agreed to participate in long-term assessment and muscle biopsy occurring a mean 267 ± 98 days after discharge. Muscle tissue from COVID exhibited a greater abundance of M2-like macrophages and satellite cells and lower activity of mitochondrial complex II and complex IV compared with controls. Conclusions: Our findings suggest that aberrant repair and altered mitochondrial activity in skeletal muscle associates with long-term impairments in patients surviving an ICU admission for COVID-19.
A prospective clinical study on the mechanisms underlying critical illness myopathy-A time-course approach

Nicola Cacciani,Åsa Skärlén,Ya Wen,Xiang Zhang,Alex B Addinsall,Monica Llano-Diez,Meishan Li,Lennart Gransberg,Yvette Hedström,Bo-Michael Bellander,David Nelson,Jonas Bergquist,Lars Larsson

DOI: https://doi.org/10.1002/jcsm.13104

Abstract:Background: Critical illness myopathy (CIM) is a consequence of modern critical care resulting in general muscle wasting and paralyses of all limb and trunk muscles, resulting in prolonged weaning from the ventilator, intensive care unit (ICU) treatment and rehabilitation. CIM is associated with severe morbidity/mortality and significant negative socioeconomic consequences, which has become increasingly evident during the current COVID-19 pandemic, but underlying mechanisms remain elusive. Methods: Ten neuro-ICU patients exposed to long-term controlled mechanical ventilation were followed with repeated muscle biopsies, electrophysiology and plasma collection three times per week for up to 12 days. Single muscle fibre contractile recordings were conducted on the first and final biopsy, and a multiomics approach was taken to analyse gene and protein expression in muscle and plasma at all collection time points. Results: (i) A progressive preferential myosin loss, the hallmark of CIM, was observed in all neuro-ICU patients during the observation period (myosin:actin ratio decreased from 2.0 in the first to 0.9 in the final biopsy, P < 0.001). The myosin loss was coupled to a general transcriptional downregulation of myofibrillar proteins (P < 0.05; absolute fold change >2) and activation of protein degradation pathways (false discovery rate [FDR] <0.1), resulting in significant muscle fibre atrophy and loss in force generation capacity, which declined >65% during the 12 day observation period (muscle fibre cross-sectional area [CSA] and maximum single muscle fibre force normalized to CSA [specific force] declined 30% [P < 0.007] and 50% [P < 0.0001], respectively). (ii) Membrane excitability was not affected as indicated by the maintained compound muscle action potential amplitude upon supramaximal stimulation of upper and lower extremity motor nerves. (iii) Analyses of plasma revealed early activation of inflammatory and proinflammatory pathways (FDR < 0.1), as well as a redistribution of zinc ions from plasma. Conclusions: The mechanical ventilation-induced lung injury with release of cytokines/chemokines and the complete mechanical silencing uniquely observed in immobilized ICU patients affecting skeletal muscle gene/protein expression are forwarded as the dominant factors triggering CIM.
COVID-19 in advanced Duchenne/Becker muscular dystrophy patients

Hagit Levine,Dario Prais,Sharon Aharoni,Yoram Nevo,Julia Katz,Eyal Rahmani,Lotem Goldberg,Oded Scheuerman

DOI: https://doi.org/10.1016/j.nmd.2021.03.011

Abstract:Duchenne muscular dystrophy (DMD) is the most common childhood muscular dystrophy. As a result of progressive muscle weakness, pulmonary function decreases during the second decade of life and lung disease contributes significantly to morbidity and mortality in these patients. Corticosteroids are the current standard of care for patients with DMD, despite known adverse effects such as obesity and immunosuppression. Over the past year (2020), the novel coronavirus (COVID-19/SARS-CoV2) outbreak has caused a global pandemic. Restrictive lung disease due to low lung volumes, chronic immunosuppressive treatment with corticosteroids, and obesity are potential risk factors that may contribute to a more severe course of the disease. Out of 116 Duchenne/Becker muscular dystrophy patients treated in our tertiary neuromuscular center, six patients with DMD and one with advanced Becker muscular dystrophy were found to be positive for COVID-19 infection. Two of the DMD patients were admitted for hospitalization, of whom one was dependent on daily nocturnal non-invasive ventilation. All patients recovered without complications despite obesity, steroid treatment and severe restrictive lung disease.
Skeletal muscle alterations in patients with acute Covid‐19 and post‐acute sequelae of Covid‐19

Madu N. Soares,Moritz Eggelbusch,Elie Naddaf,Karin H. L. Gerrits,Marike Schaaf,Bram Borst,W. Joost Wiersinga,Michele Vugt,Peter J.M. Weijs,Andrew J. Murray,Rob C.I. Wüst

DOI: https://doi.org/10.1002/jcsm.12896

2022-01-07

Abstract:Skeletal muscle-related symptoms are common in both acute coronavirus disease (Covid)-19 and post-acute sequelae of Covid-19 (PASC). In this narrative review, we discuss cellular and molecular pathways that are affected and consider these in regard to skeletal muscle involvement in other conditions, such as acute respiratory distress syndrome, critical illness myopathy, and post-viral fatigue syndrome. Patients with severe Covid-19 and PASC suffer from skeletal muscle weakness and exercise intolerance. Histological sections present muscle fibre atrophy, metabolic alterations, and immune cell infiltration. Contributing factors to weakness and fatigue in patients with severe Covid-19 include systemic inflammation, disuse, hypoxaemia, and malnutrition. These factors also contribute to post-intensive care unit (ICU) syndrome and ICU-acquired weakness and likely explain a substantial part of Covid-19-acquired weakness. The skeletal muscle weakness and exercise intolerance associated with PASC are more obscure. Direct severe acute respiratory syndrome coronavirus (SARS-CoV)-2 viral infiltration into skeletal muscle or an aberrant immune system likely contribute. Similarities between skeletal muscle alterations in PASC and chronic fatigue syndrome deserve further study. Both SARS-CoV-2-specific factors and generic consequences of acute disease likely underlie the observed skeletal muscle alterations in both acute Covid-19 and PASC.

medicine, general & internal,geriatrics & gerontology,gerontology
Respiratory muscle strength in ischemic cardiomyopathy and COVID-19 patients.

Gutierrez-Luna,E.,Sanchez,R.,Orea,A.,Gonzalez,D.,Pena,T.,Albarran,F.,Aguirre,A.,Xospa,E.,Sanchez,A.,Garcia,A.,Sanchez,K.,Valderrabano,B.,Vigil,C.,Zurita,A.,Arcos,L.,ALBARRAN LOPEZ,F.

DOI: https://doi.org/10.1183/13993003.congress-2024.pa5271

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:Less respiratory muscle strength is associated with deteriorated respiratory function and worse quality of life. It is well-known that acute and chronic diseases negatively impact muscular mass and strength. However, the association of ischemic cardiomyopathy and respiratory muscle strength is not well-established in long COVID-19 patients. To evaluate respiratory strength mass and pulmonary function in subjects with ischemic cardiomyopathy and long COVID-19. In this prospective cohort study, patients with a long COVID-19 needed hospitalization during the acute phase. The maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) assessed respiratory muscle strength. Exercise tolerance was evaluated by a six-minute walk test (6MWT). 545 patients were studied. Subjects with ischemic cardiomyopathy had higher prevalence of systemic arterial hypertension and COPD, as well lower MIP, MEP, peak expiratory flow, forced vital capacity. It is known that with ischemic cardiomyopathy, there are alterations in body composition. Our study shows that there is also a reduction in the strength of respiratory muscles, which negatively impacts pulmonary function and quality of life of patients with long COVID-19, who also show a higher prevalence of comorbidities such as arterial hypertension and COPD. Patients with ischemic cardiomyopathy and long COVID-19 have reduced strength in respiratory muscles.

respiratory system
Decreased phrenic nerve compound muscle action potential, inspiratory muscle strength, and exercise capacity after COVID-19

Karin Vonbank,Helena Nics,Ralf Harun Zwick,Julia Maasz,Benjamin Sabic,Marijan Potzmann,Georg Brandhofer,Julia Fuchs,Lusine Yeghiazaryan,Martin Burtscher,Tatjana Paternostro-Sluga

DOI: https://doi.org/10.3389/fneur.2023.1308443

IF: 3.4

2024-01-17

Frontiers in Neurology

Abstract:Objectives: Respiratory muscle weakness with higher ventilatory demands were reported even in patients recovering from only mild COVID-19 symptoms. Aim of this study was to assess the function of phrenic nerve and inspiratory respiratory muscle as well as cardiopulmonary exercise capacity in patients with prolonged exertional dyspnea after COVID-19 infection. Methods: In this observational exploratory study, electrophysiological examination of the phrenic nerve, inspiratory muscle capacity as well as lung function test, 6-min walk distance (6MWD) and cardiopulmonary exercise test, have been performed in 22 patients post COVID-19 diagnosis (post-CoV). Results: Exercise capacity (peak workload, Wpeak % predicted and peak oxygen uptake, VO 2 peak % predicted) were significantly affected in the post-CoV patients (61.8 ± 23.3 Wpeak % and 70.9 ± 22.3 VO 2 peak %). Maximum inspiratory pressure (MIP) was reduced (60.1 ± 25.5 mbar). In 6 of the 22 patients the electrophysiological response of the phrenic nerve was pathologically decreased (reduced compound muscle action potential, CMAP), while nerve conduction velocity (NCV) was normal, which corresponds to reduced muscle fiber contraction capacity. Positive relationships were demonstrated between 6MWD and MIP ( r s = 0.88) as well as quality of life questionnaire (CRQ) and MIP ( r s = 0.71) only in patients with reduced CMAP. Discussion: Respiratory muscle weakness and exercise capacity is associated with reduced phrenic nerve CMAP without signs of neuropathy. This indicates that muscle fiber pathology of the diaphragm may be one pathophysiological factor for the prolonged respiratory symptoms after COVID-19 infections.

neurosciences,clinical neurology
Efficacy of speech and language therapy for particular speech sounds in children.

J. Munro

DOI: https://doi.org/10.3109/13682829809179467

1998-10-01

Abstract:At the present time there is a demand for research into the efficacy of speech and language therapy. This study aims to assess the efficacy of therapy provided in South Tees for children who do not use word-initial velar plosives. The study is in progress at the time of writing and it is expected that therapy will be completed by July 1998. Subjects are split randomly into an 'immediate treatment' and a 'deferred treatment' group. All subjects are reassessed after treatment of each group. It is of course possible that analysis of the results will not show a significant difference between pre- and post-treatment scores. Some children may acquire target sounds before entering therapy, whilst others may fail to learn them within the treatment period. Various factors are being noted to determine whether they appear to correlate with the outcome of therapy.
Unveiling the detrimental vicious cycle linking skeletal muscle and COVID-19: A systematic review and meta-analysis

Qin Wang,Peipei Shi,Lu Cao,Haoran Li,Xiankai Chen,Peiyu Wang,Jianjiang Zhang

DOI: https://doi.org/10.1111/jebm.12629

2024-07-08

Abstract:Objective: Skeletal muscle catabolism supports multiple organs and systems during severe trauma and infection, but its role in COVID-19 remains unclear. This study investigates the interactions between skeletal muscle and COVID-19. Methods: The PubMed, EMbase, and The Cochrane Library databases were systematically searched from January 2020 to August 2023 for cohort studies focusing on the impact of skeletal muscle on COVID-19 prevalence and outcomes, and longitudinal studies examining skeletal muscle changes caused by COVID-19. Skeletal muscle quantity (SMQN) and quality (SMQL) were assessed separately. The random-effect model was predominantly utilized for statistical analysis. Results: Seventy studies with moderate to high quality were included. Low SMQN/SMQL was associated with an increased risk of COVID-19 infection (OR = 1.62, p < 0.001). Both the low SMQN and SMQL predicted COVID-19-related mortality (OR = 1.53, p = 0.016; OR = 2.18, p = 0.001, respectively). Mortality risk decreased with increasing SMQN (OR = 0.979, p = 0.009) and SMQL (OR = 0.972, p = 0.034). Low SMQN and SMQL were also linked to the need for intensive care unit/mechanical ventilation, increased COVID-19 severity, and longer hospital stays. Significant skeletal muscle wasting, characterized by reduced volume and strength, was observed during COVID-19 infection and the pandemic. Conclusions: This study reveals a detrimental vicious circle between skeletal muscle and COVID-19. Effective management of skeletal muscle could be beneficial for treating COVID-19 infections and addressing the broader pandemic. These findings have important implications for the management of future virus pandemics. Systematic review registration: PROSPERO CRD42023395476.
Case Report: Myopathy in Critically Ill COVID-19 Patients: A Consequence of Hyperinflammation?

Viviana Versace,Luca Sebastianelli,Davide Ferrazzoli,Leopold Saltuari,Markus Kofler,Wolfgang Löscher,Antonino Uncini

DOI: https://doi.org/10.3389/fneur.2021.625144

IF: 3.4

2021-01-29

Frontiers in Neurology

Abstract:Introduction: COVID-19-associated muscular complications may comprise myalgia, weakness, wasting, and rhabdomyolysis. Skeletal muscle damage in COVID-19 may be due to direct infection by the virus SARS-CoV-2 through interaction with the ACE2 receptor, systemic hyper-inflammatory state with cytokine release and homeostatic perturbation, an autoimmune process, or myotoxic drugs. Disclosing the cause of weakness in an individual patient is therefore difficult. Case Description: We report two patients, who survived typical COVID-19 pneumonia requiring intensive care treatment and who developed early on myalgia and severe proximal weakness in all four limbs. Laboratory exams revealed elevated serum creatine kinase and markedly increased C-reactive protein and interleukin 6, concurring with a systemic inflammatory response. On admission in neurorehabilitation (4 and 7 weeks after COVID-19 onset, respectively), the patients presented with proximal flaccid tetraparesis and limb-girdle muscle atrophy. Motor nerve conduction studies showed decreased amplitude and prolonged duration of compound muscle action potentials (CMAPs) with normal distal motor latencies and normal conduction velocities in median and ulnar nerves. Needle electromyography in proximal muscles revealed spontaneous activity in one and myopathic changes in both patients. Discussion: Clinical, laboratory, and electrodiagnostic findings in these patients were unequivocally consistent with myopathy. Interestingly, increased distal CMAP duration has been described in patients with critical illness myopathy (CIM) and reflects slow muscle fiber conduction velocity due to membrane hypo-excitability, possibly induced by inflammatory cytokines. By analogy with CIM, the pathogenesis of COVID-19-related myopathy might also depend on hyperinflammation and metabolic pathways that may affect muscles in a pathophysiological continuum from hypo-excitability to necrosis.

neurosciences,clinical neurology
Abstract 310: Mechanistic Insights into Duchenne Muscular Dystrophy-Associated Cardiomyopathy

Tara Tassin,Jian Huang,Terry Gemelli,Mohammed Kanchwala,Lisa M. Punnen,Emily Chung,Dylan Rivas,Sean Goetsch,Juan A. Daniel,John Shelton,James A. Richardson,Jay Schneider,C. Xing,S. Singh,P. P. Mammen

DOI: https://doi.org/10.1161/res.123.suppl_1.310

IF: 23.213

2018-01-01

Circulation Research

Abstract:Duchenne muscular dystrophy (DMD) is an X-linked neuromuscular disorder resulting from a mutation in the dystrophin gene. Loss of dystrophin function leads to progressive muscle wasting and cardiomyopathy. In 2018, advanced cardiomyopathy is the primary mode of death, despite the application of standard of care CHF therapies. Our group has recently undertaken a cardiac MRI study demonstrating that adult DMD patients have small hearts with very low LV mass as compared to patients with non-ischemic cardiomyopathy or healthy patients. The central hypothesis is DMD-associated cardiomyopathy develops secondary to dysregulation of various cardiac signaling pathways that modulate cardiac growth, namely cardiomyocyte proliferation. Utilizing the mdx mouse, a model of DMD, decreased heart/body weight ratios were noted from birth (P1: Hrt/BW 5.6 ± 0.16 vs. 4.8 ± 0.18 NTg vs mdx p<0.005 n=32). NTg and m dx hearts have similar cardiomyocyte cell size (WGA staining: 0.08 ± 0.001 vs 0.08 ± 0.002 NTg vs mdx p<0.05 n=3), suggesting there are fewer cells in mdx hearts. FACS analysis indicated mdx hearts have fewer cardiomyocytes than NTg hearts (35% reduction; 51.7e 4 ± 4.9e 4 vs. 33.8e 4 ± 3.5e 4 NTg vs mdx p<0.05 n=6). Transcriptome profiling demonstrated that molecular pathways governing cardiac proliferation were significantly reduced in mdx hearts (Ki67: 4.8 ± 0.3 vs 2.0 ± 0.1 NTg vs mdx p<0.005 n=3), with a corresponding increase in cardiac atrophy gene expression at later time points (Foxo3 1.4 ± 0.2 vs 2.8 ± 0.3 NTg vs mdx p<0.005 n=3). Furthermore, immunohistochemical analyses showed significantly reduced proliferation in mdx hearts (Ki67: 13.7 ± 1.2 vs. 6.0 ± 1.0 NTg vs mdx p<0.005, n=3; pH3: 118 ± 5.3 vs 59 ± 4.5 p<0.005 n=3). Finally, RNA-Seq data revealed a disruption of the YAP signaling pathway, an important mediator of cardiomyocyte proliferation, in mdx P4 hearts. Cell cycle targets of YAP were reduced in P4 mdx hearts (20/27 genes, n=3) suggesting a disruption of the Hippo-Yap pathways in mdx hearts. Collectively, the current study provides a unique insight into the mechanism leading to the development DMD cardiomyopathy and directs investigation into potential therapeutic targets for the amelioration of DMD-associated cardiomyopathy.
A new phenotype of patients with post-COVID-19 condition is characterised by a pattern of complex ventilatory dysfunction, neuromuscular disturbance and fatigue symptoms

Fridolin Steinbeis,Claudia Kedor,Hans-Jakob Meyer,Charlotte Thibeault,Mirja Mittermaier,Philipp Knape,Katharina Ahrens,Gabriele Rotter,Bettina Temmesfeld-Wollbrück,Leif Erik Sander,Florian Kurth,Martin Witzenrath,Carmen Scheibenbogen,Thomas Zoller

DOI: https://doi.org/10.1183/23120541.01027-2023

2024-10-07

Abstract:Background: Patients with post-COVID-19 condition frequently suffer from chronic dyspnoea. The causes and mechanism for dyspnoea in these patients without evidence of structural lung disease are unclear. Methods: Patients treated for COVID-19 at Charité University Hospital in Berlin received pulmonary function testing including respiratory muscle strength tests and completed health-related quality-of-life questionnaires during follow-up. Patients with post-COVID-19 condition during outpatient follow-up with fatigue and exertional intolerance (PCF) were compared to patients with post-COVID-19 condition with evidence of chronic pulmonary sequelae (post-COVID-19 restriction (PCR)) as well as to patients without post-COVID-19 condition (NCF). Results: A total of 170 patients presented for follow-up. 36 participants met criteria for PCF, 28 for PCR and 24 for NCF. PCF patients reported dyspnoea in 63.8%. % predicted value of respiratory muscle strength (median (IQR)) was reduced in PCF (55.8 (41.5-75.9)) compared to NCF and PCR (70.6 (66.3-88.9) and 76.8 (63.6-102.2), respectively; p=0.011). A pattern of reduced forced vital capacity (FVC), but normal total lung capacity (TLC), termed complex ventilatory dysfunction defined as TLC - FVC >10% predicted was observed and occurred more frequently in PCF (88.9%) compared to NCF and PCR (29.1% and 25.0%, respectively; p<0.001). Conclusion: Dyspnoea in PCF is characterised by reduced respiratory muscle strength and complex ventilatory dysfunction indicating neuromuscular disturbance as a distinct phenotype among patients with post-COVID-19 condition. These observations could be a starting point for developing personalised rehabilitation concepts.
From heart to muscle: pathophysiological mechanisms underlying long-term physical sequelae from SARS-CoV-2 infection

Corinna Serviente,Stephen T Decker,Gwenael Layec,Stephen T. Decker

DOI: https://doi.org/10.1152/japplphysiol.00734.2021

2022-03-01

Journal of Applied Physiology

Abstract:The long-term sequelae of the coronavirus disease 2019 (COVID-19) are multifaceted and, besides the lungs, impact other organs and tissues, even in cases of mild infection. Along with commonly reported symptoms such as fatigue and dyspnea, a significant proportion of those with prior COVID-19 infection also exhibit signs of cardiac damage, muscle weakness, and ultimately, poor exercise tolerance. This review provides an overview of evidence indicating cardiac impairments and persistent endothelial dysfunction in the peripheral vasculature of those previously infected with COVID-19, irrespective of the severity of the acute phase of illness. In addition, V̇o 2peak appears to be lower in convalescent patients, which may stem, in part, from alterations in O 2 transport such as impaired diffusional O 2 conductance. Together, the persistent multi-organ dysfunction induced by COVID-19 may set previously healthy individuals on a trajectory towards frailty and disease. Given the large proportion of individuals recovering from COVID-19, it is critically important to better understand the physical sequelae of COVID-19, the underlying biological mechanisms contributing to these outcomes, and the long-term effects on future disease risk. This review highlights relevant literature on the pathophysiology post-COVID-19 infection, gaps in the literature, and emphasizes the need for the development of evidence-based rehabilitation guidelines.

physiology,sport sciences
Soluble IL-2R impairs muscle cell mitochondrial respiration in fatigued individuals with post-acute sequelae of COVID-19.

Laura Peterson Brown,Jai Joshi,Kate Kosmac,Douglas E Long,Ashley A Montgomery-Yates,Anna G Kalema,Jamie Sturgill,Hemendra Vekaria,Patrick Sullivan,Dylan Wilburn,Panagiotis Koutakis,Christine M Latham,Christopher Fry,Philip A Kern,Benjamin Miller,Esther Dupont-Versteegden,Ahmed Ismaeel,Kirby P Mayer,Yuan Wen

DOI: https://doi.org/10.1101/2024.08.14.24311980

2024-08-20

Abstract:Post-acute sequelae of COVID (PASC) persist in many patients for weeks and months after recovery from initial SARS-CoV-2 infection. Recent evidence suggests that pathological changes in skeletal muscle may contribute significantly to ongoing pain and fatigue, particularly post-exertional malaise. This study aimed to investigate the underlying mechanisms of PASC-related fatigue by examining skeletal muscle function and circulating factors in affected individuals. We conducted a cross-sectional case-control study of patients with fatigue-associated PASC who had experienced mild to moderate COVID-19 without hospitalization. Skeletal muscle biopsies revealed reduced mitochondrial respiration and content in PASC participants compared to healthy controls. This lower respiratory capacity was accompanied by markedly elevated circulating levels of soluble IL-2 receptor alpha subunit (sIL2R), a T cell-specific receptor. In vitro experiments demonstrated that sIL2R directly impairs mitochondrial oxygen consumption and reduces mitochondrial complex III subunit protein levels in cultured muscle cells. These findings suggest a mechanism linking systemic immune dysregulation to muscle-specific mitochondrial dysfunction in PASC. This work provides new insights into the pathophysiology of PASC identifying sIL2R as a promising therapeutic target for addressing mitochondrial deficits in PASC-related fatigue and opening avenues for developing targeted interventions.

Rehabilitation Medicine and Physical Therapy
Suthi feeding: an experience.

B. D. Gupta,P. Jain,S. Mandowara

1995-06-01

Indian Pediatrics

Abstract: In cases in which expressed breast milk is given or breast feeding cannot be done at all, a suitable alternative to breast feeding is still in question. Bottle feeding poses many hazards. Spoon and bowl have been proposed as a reasonable alternative since users can achieve better cleanliness. Yet it is impractical for staff in health facility nurseries to feed every newborn with the spoon and bowl method since it requires so much time. On average, they need to provide oral feeds to at least 10 babies a day. In India, maternal grandparents present the family of a newborn with the traditional Sindhi silver or stainless steel utensil to provide the infant drinking water. It is called Suthi. It holds either 10 or 20 cc, making it easier to quantify the amount of milk/feed. It has a long semicircular beak and curved rounded margins. Advantages of the Suthi over other alternative feeding methods include: it is a shallow container with a broad upper surface, allowing the user to clean it thoroughly and easily; its narrow beak can go directly into the mouth of the newborn, particularly premature infants and low birth weight infants, with relative ease, reducing the likelihood of spilling milk, and the Suthi feeding procedure is less messy and faster (7-10 vs. 15-20 minutes for spoon) than other procedures. The Suthi method allows nursery staff to spend less time per feed for 8-10 babies (minimum time needed, 1 vs. 3 hours). It can also be used at home. Its use will reduce the likelihood of aspiration since it cannot be used lying down. Since it is a traditional container, the community will accept Suthi. When breast feeding is not possible, the Suthi should be used.
In vivo shear wave elasticity imaging for assessment of diaphragm function in muscular dystrophy

Jeehyun Lee,Nia O Myrie,Gun-Jae Jeong,Woojin M Han,Young C Jang,Andrés J García,Stanislav Emelianov,Nia O. Myrie,Gun-jae Jeong,Woojin M. Han,Young C. Jang,Andrés J. García

DOI: https://doi.org/10.1016/j.actbio.2023.07.009

IF: 10.633

2023-07-14

Acta Biomaterialia

Abstract:Duchenne muscular dystrophy (DMD) causes patients to suffer from ambulatory disability and cardiorespiratory failure, the latter of which leads to premature death. Due to its role in respiration, the diaphragm is an important muscle for study. A common method for evaluating diaphragm function is ex vivo force testing, which only allows for an end point measurement. In contrast, ultrasound shear wave elastography imaging (US-SWEI) can assess diaphragm function over time; however, US-SWEI studies in dystrophic patients to date have focused on the limbs without preclinical studies. In this work, we used US-SWEI to estimate the shear wave speed (SWS) in diaphragm muscles of healthy (WT) mice, mdx mice, and mdx mice haploinsufficient for utrophin ( mdx -utr) at 6 and 12 months of age. Diaphragms were then subjected to ex vivo force testing and histological analysis at 12 months of age. Between 6 and 12 months, a 23.8% increase in SWS was observed in WT mice and a 27.8% increase in mdx mice, although no significant difference was found in mdx -utr mice. Specific force generated by mdx -utr diaphragms was lower than that of WT diaphragms following twitch stimulus. A strong correlation between SWS and collagen deposition was observed, as well as between SWS and muscle fiber size. Together, these data demonstrate the ability of US-SWEI to evaluate dystrophic diaphragm functionality over time and predict the biochemical and morphological make-up of the diaphragm. Additionally, our results highlight the advantage of US-SWEI over ex vivo testing by obtaining longitudinal measurements in the same subject. Statement of Significance In DMD patients, muscles experience cycles of regeneration and degeneration that contribute to chronic inflammation and muscle weakness. This pathology only worsens with time and leads to muscle wasting, including in respiratory and cardiac muscles. Because respiratory failure is a major contributor to premature death in DMD patients, the diaphragm muscle is an important muscle to evaluate and treat over time. Currently, diaphragm function is assessed using ex vivo force testing, a technique that only allows measurement at sacrifice. In contrast, ultrasonography, particularly shear wave elasticity imaging (US-SWEI), is a promising tool for longitudinal assessment; however, most US-SWEI in DMD patients aimed for limb muscles only with the absence of preclinical studies. This work broadens the applications of US-SWE imaging by demonstrating its ability to track properties and function of dystrophic diaphragm muscles longitudinally in multiple dystrophic mouse models.

engineering, biomedical,materials science, biomaterials
Muscle Dysfunction and Functional Status in COVID-19 Patients during Illness and after Hospital Discharge

Otakar Psenicka,Tomas Brutvan,Jan Kratky,Jarmila Krizova

DOI: https://doi.org/10.3390/biomedicines12020460

IF: 4.757

2024-02-19

Biomedicines

Abstract:Background: COVID-19 pneumonia is associated with SIRS and hypercatabolism. The aim of this study was to determine muscle loss during the acute phase of COVID-19 pneumonia and evaluate long-term sequelae in discharged patients. Methods: A total of 16 patients with COVID-19 pneumonia and respiratory insufficiency were included in the study. Selected parameters (weight, BMI, LBM = lean body mass, albumin, CRP, NLR = neutrophil-to-lymphocyte ratio, ultrasound measured thickness of rectus femoris muscle = US RF and rectus femoris + vastus intermedius = US RF + VI, handgrip strength, quality of life = EQ-5D questionnaire, and activities of daily living = Barthel's ADLs) were recorded on admission, discharge, and 1, 3, and 6 months after discharge. Results: The most significant changes were between hospital admission and discharge: US RF and RF + VI (−1.28 ± 1.97 mm, p = 0.046; −1.76 ± 2.94 mm, p = 0.05), EQ-5D score (14.6 ± 19.2, p = 0.02), and ADLs (17.1 ± 22.6; p = 0.02). There was a significant positive correlation between US RF + VI and handgrip strength (p = 0.014) and a negative correlation between weight and Barthel index (p = 0.012). There was an association between muscle function with an EQ-5D score and ADLs during outpatient check-ups, most noticeably between handgrip strength, US RF+VI, and ADLs (p = 0.08; p = 0.1, respectively). Conclusions: In patients with COVID-19 pneumonia, there is a significant reduction of health-related quality of life, impaired even 6 months after hospital discharge, influenced mainly by muscle loss. During the hospital stay, there was a significant muscle mass reduction. Ultrasound measurement of thigh muscle thickness may be a useful method to monitor muscle loss.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
[Delayed allergy to indocyanine green (ICG) and bromsulphalein (BSP) studied by means of leukocyte migration inhibition test].

J. Juszczyk,A. Szkaradkiewicz,J. Adamek

1975-08-04

Abstract:

Gehirnveränderungen bei Schwangerschaftstoxikose

Potential Diaphragm Muscle Weakness-related Dyspnea Persists 2 Years after COVID-19 and Could Be Improved by Inspiratory Muscle Training: Results of an Observational and an Interventional Clinical Trial

Continuous Femoral Nerve Blocks: Decreasing Local Anesthetic Concentration to Minimize Quadriceps Femoris Weakness

Options and processes for spent catalyst handling and utilization.

Persistent Fatigue, Weakness, and Aberrant Muscle Mitochondria in Survivors of Critical COVID-19

A prospective clinical study on the mechanisms underlying critical illness myopathy-A time-course approach

COVID-19 in advanced Duchenne/Becker muscular dystrophy patients

Skeletal muscle alterations in patients with acute Covid‐19 and post‐acute sequelae of Covid‐19

Respiratory muscle strength in ischemic cardiomyopathy and COVID-19 patients.

Decreased phrenic nerve compound muscle action potential, inspiratory muscle strength, and exercise capacity after COVID-19

Efficacy of speech and language therapy for particular speech sounds in children.

Unveiling the detrimental vicious cycle linking skeletal muscle and COVID-19: A systematic review and meta-analysis

Case Report: Myopathy in Critically Ill COVID-19 Patients: A Consequence of Hyperinflammation?

Abstract 310: Mechanistic Insights into Duchenne Muscular Dystrophy-Associated Cardiomyopathy

A new phenotype of patients with post-COVID-19 condition is characterised by a pattern of complex ventilatory dysfunction, neuromuscular disturbance and fatigue symptoms

From heart to muscle: pathophysiological mechanisms underlying long-term physical sequelae from SARS-CoV-2 infection

Soluble IL-2R impairs muscle cell mitochondrial respiration in fatigued individuals with post-acute sequelae of COVID-19.

Suthi feeding: an experience.

In vivo shear wave elasticity imaging for assessment of diaphragm function in muscular dystrophy

Muscle Dysfunction and Functional Status in COVID-19 Patients during Illness and after Hospital Discharge

[Delayed allergy to indocyanine green (ICG) and bromsulphalein (BSP) studied by means of leukocyte migration inhibition test].